Showing results (81-90 of 158) with videos related to
Sort By:
Pageof 16
British Journal of Rheumatology|February 1, 1987
The clinical significance of the anticentromere antibodyM H Miller, G O Littlejohn, A Davidson, et al.Clinical and Experimental Immunology|September 1, 1985
Impaired release of a T-cell specific suppressor factor in rheumatoid arthritisC Lau, S Budz-Tymkewycz, M Ramsden, et al.The Journal of Rheumatology|September 1, 1981
Antigen-specific suppressor cell activity in patients with sclerodermaE C Keystone, D D Gladman, M Baron, et al.Journal of Internal Medicine|September 26, 2015
Biosimilars in immune-mediated inflammatory diseases: initial lessons from the first approved biosimilar anti-tumour necrosis factor monoclonal antibodyJ D Isaacs, M Cutolo, E C Keystone, et al.Clinical Immunology and Immunopathology|May 1, 1992
Impaired generation of high-affinity interleukin-2 receptors in the autologous mixed lymphocyte reaction in rheumatoid arthritisF Akasu, L Poplonski, K M Snow, et al.The Journal of Investigative Dermatology|November 1, 1981
Impaired antigen-specific suppressor cell activity in psoriasis and psoriatic arthritisD D Gladman, E C Keystone, M L Russell, et al.Arthritis and Rheumatism|November 1, 1980
Impaired antigen-specific suppressor cell activity in patients with rheumatoid arthritisE C Keystone, D D Gladman, R Buchanan, et al.The Journal of Rheumatology|August 1, 1986
In vivo activation of lymphocytes in rheumatoid arthritisE C Keystone, L Poplonski, R G Miller, et al.Clinical and Experimental Immunology|October 1, 1981
Lymphocyte subpopulations and reactivity to mitogens in patients with sclerodermaM Baron, E C Keystone, D D Gladman, et al.JAMA|May 8, 1981
Intra-arterial alprostadil for nonatherosclerotic vasculopathyD L Wooster, C J Shamess, P N Madras, et al.Pageof 16